1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Eye Disorders 1.2.3 Hematological Disorders 1.2.4 Central Nervous System Disorders 1.2.5 Muscular Disorders 1.2.6 Others 1.3 Market by Application 1.3.1 Global Gene Therapy for Inherited Genetic Disorders Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Research Institute 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Gene Therapy for Inherited Genetic Disorders Market Perspective (2016-2027) 2.2 Gene Therapy for Inherited Genetic Disorders Growth Trends by Regions 2.2.1 Gene Therapy for Inherited Genetic Disorders Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Gene Therapy for Inherited Genetic Disorders Historic Market Share by Regions (2016-2021) 2.2.3 Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Regions (2022-2027) 2.3 Gene Therapy for Inherited Genetic Disorders Industry Dynamic 2.3.1 Gene Therapy for Inherited Genetic Disorders Market Trends 2.3.2 Gene Therapy for Inherited Genetic Disorders Market Drivers 2.3.3 Gene Therapy for Inherited Genetic Disorders Market Challenges 2.3.4 Gene Therapy for Inherited Genetic Disorders Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Gene Therapy for Inherited Genetic Disorders Players by Revenue 3.1.1 Global Top Gene Therapy for Inherited Genetic Disorders Players by Revenue (2016-2021) 3.1.2 Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Players (2016-2021) 3.2 Global Gene Therapy for Inherited Genetic Disorders Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Gene Therapy for Inherited Genetic Disorders Revenue 3.4 Global Gene Therapy for Inherited Genetic Disorders Market Concentration Ratio 3.4.1 Global Gene Therapy for Inherited Genetic Disorders Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy for Inherited Genetic Disorders Revenue in 2020 3.5 Gene Therapy for Inherited Genetic Disorders Key Players Head office and Area Served 3.6 Key Players Gene Therapy for Inherited Genetic Disorders Product Solution and Service 3.7 Date of Enter into Gene Therapy for Inherited Genetic Disorders Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Gene Therapy for Inherited Genetic Disorders Breakdown Data by Type 4.1 Global Gene Therapy for Inherited Genetic Disorders Historic Market Size by Type (2016-2021) 4.2 Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Type (2022-2027) 5 Gene Therapy for Inherited Genetic Disorders Breakdown Data by Application 5.1 Global Gene Therapy for Inherited Genetic Disorders Historic Market Size by Application (2016-2021) 5.2 Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Gene Therapy for Inherited Genetic Disorders Market Size (2016-2027) 6.2 North America Gene Therapy for Inherited Genetic Disorders Market Size by Type 6.2.1 North America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021) 6.2.2 North America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2022-2027) 6.2.3 North America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2027) 6.3 North America Gene Therapy for Inherited Genetic Disorders Market Size by Application 6.3.1 North America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2021) 6.3.2 North America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2022-2027) 6.3.3 North America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2027) 6.4 North America Gene Therapy for Inherited Genetic Disorders Market Size by Country 6.4.1 North America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2016-2021) 6.4.2 North America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size (2016-2027) 7.2 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type 7.2.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021) 7.2.2 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2022-2027) 7.2.3 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2027) 7.3 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application 7.3.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2021) 7.3.2 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2022-2027) 7.3.3 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2027) 7.4 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country 7.4.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2016-2021) 7.4.2 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size (2016-2027) 8.2 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Type 8.2.1 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2027) 8.3 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Application 8.3.1 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2027) 8.4 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Region 8.4.1 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Gene Therapy for Inherited Genetic Disorders Market Size (2016-2027) 9.2 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type 9.2.1 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021) 9.2.2 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2022-2027) 9.2.3 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2027) 9.3 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application 9.3.1 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2021) 9.3.2 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2022-2027) 9.3.3 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2027) 9.4 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country 9.4.1 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2016-2021) 9.4.2 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size (2016-2027) 10.2 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Type 10.2.1 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2027) 10.3 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Application 10.3.1 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2027) 10.4 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Country 10.4.1 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 BioMarin Pharmaceutical Inc. 11.1.1 BioMarin Pharmaceutical Inc. Company Details 11.1.2 BioMarin Pharmaceutical Inc. Business Overview 11.1.3 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Introduction 11.1.4 BioMarin Pharmaceutical Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2016-2021) 11.1.5 BioMarin Pharmaceutical Inc. Recent Development 11.2 bluebird bio Inc. 11.2.1 bluebird bio Inc. Company Details 11.2.2 bluebird bio Inc. Business Overview 11.2.3 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Introduction 11.2.4 bluebird bio Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2016-2021) 11.2.5 bluebird bio Inc. Recent Development 11.3 Novartis AG 11.3.1 Novartis AG Company Details 11.3.2 Novartis AG Business Overview 11.3.3 Novartis AG Gene Therapy for Inherited Genetic Disorders Introduction 11.3.4 Novartis AG Revenue in Gene Therapy for Inherited Genetic Disorders Business (2016-2021) 11.3.5 Novartis AG Recent Development 11.4 Orchard Therapeutics Plc 11.4.1 Orchard Therapeutics Plc Company Details 11.4.2 Orchard Therapeutics Plc Business Overview 11.4.3 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Introduction 11.4.4 Orchard Therapeutics Plc Revenue in Gene Therapy for Inherited Genetic Disorders Business (2016-2021) 11.4.5 Orchard Therapeutics Plc Recent Development 11.5 Spark Therapeutics Inc. 11.5.1 Spark Therapeutics Inc. Company Details 11.5.2 Spark Therapeutics Inc. Business Overview 11.5.3 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Introduction 11.5.4 Spark Therapeutics Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2016-2021) 11.5.5 Spark Therapeutics Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Eye Disorders Table 3. Key Players of Hematological Disorders Table 4. Key Players of Central Nervous System Disorders Table 5. Key Players of Muscular Disorders Table 6. Key Players of Others Table 7. Global Gene Therapy for Inherited Genetic Disorders Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Gene Therapy for Inherited Genetic Disorders Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Gene Therapy for Inherited Genetic Disorders Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Gene Therapy for Inherited Genetic Disorders Market Share by Regions (2016-2021) Table 11. Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Gene Therapy for Inherited Genetic Disorders Market Share by Regions (2022-2027) Table 13. Gene Therapy for Inherited Genetic Disorders Market Trends Table 14. Gene Therapy for Inherited Genetic Disorders Market Drivers Table 15. Gene Therapy for Inherited Genetic Disorders Market Challenges Table 16. Gene Therapy for Inherited Genetic Disorders Market Restraints Table 17. Global Gene Therapy for Inherited Genetic Disorders Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Gene Therapy for Inherited Genetic Disorders Market Share by Players (2016-2021) Table 19. Global Top Gene Therapy for Inherited Genetic Disorders Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy for Inherited Genetic Disorders as of 2020) Table 20. Ranking of Global Top Gene Therapy for Inherited Genetic Disorders Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Gene Therapy for Inherited Genetic Disorders Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Gene Therapy for Inherited Genetic Disorders Product Solution and Service Table 24. Date of Enter into Gene Therapy for Inherited Genetic Disorders Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021) (US$ Million) Table 27. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Type (2016-2021) Table 28. Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Gene Therapy for Inherited Genetic Disorders Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Application (2016-2021) Table 32. Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021) (US$ Million) Table 35. North America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2021) (US$ Million) Table 37. North America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Country (2022-2027) & (US$ Million) Table 64. BioMarin Pharmaceutical Inc. Company Details Table 65. BioMarin Pharmaceutical Inc. Business Overview Table 66. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Product Table 67. BioMarin Pharmaceutical Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2016-2021) & (US$ Million) Table 68. BioMarin Pharmaceutical Inc. Recent Development Table 69. bluebird bio Inc. Company Details Table 70. bluebird bio Inc. Business Overview Table 71. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Product Table 72. bluebird bio Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2016-2021) & (US$ Million) Table 73. bluebird bio Inc. Recent Development Table 74. Novartis AG Company Details Table 75. Novartis AG Business Overview Table 76. Novartis AG Gene Therapy for Inherited Genetic Disorders Product Table 77. Novartis AG Revenue in Gene Therapy for Inherited Genetic Disorders Business (2016-2021) & (US$ Million) Table 78. Novartis AG Recent Development Table 79. Orchard Therapeutics Plc Company Details Table 80. Orchard Therapeutics Plc Business Overview Table 81. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Product Table 82. Orchard Therapeutics Plc Revenue in Gene Therapy for Inherited Genetic Disorders Business (2016-2021) & (US$ Million) Table 83. Orchard Therapeutics Plc Recent Development Table 84. Spark Therapeutics Inc. Company Details Table 85. Spark Therapeutics Inc. Business Overview Table 86. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Product Table 87. Spark Therapeutics Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2016-2021) & (US$ Million) Table 88. Spark Therapeutics Inc. Recent Development Table 89. Research Programs/Design for This Report Table 90. Key Data Information from Secondary Sources Table 91. Key Data Information from Primary Sources List of Figures Figure 1. Global Gene Therapy for Inherited Genetic Disorders Market Share by Type: 2020 VS 2027 Figure 2. Eye Disorders Features Figure 3. Hematological Disorders Features Figure 4. Central Nervous System Disorders Features Figure 5. Muscular Disorders Features Figure 6. Others Features Figure 7. Global Gene Therapy for Inherited Genetic Disorders Market Share by Application: 2020 VS 2027 Figure 8. Hospital Case Studies Figure 9. Clinic Case Studies Figure 10. Research Institute Case Studies Figure 11. Others Case Studies Figure 12. Gene Therapy for Inherited Genetic Disorders Report Years Considered Figure 13. Global Gene Therapy for Inherited Genetic Disorders Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 14. Global Gene Therapy for Inherited Genetic Disorders Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Gene Therapy for Inherited Genetic Disorders Market Share by Regions: 2020 VS 2027 Figure 16. Global Gene Therapy for Inherited Genetic Disorders Market Share by Regions (2022-2027) Figure 17. Global Gene Therapy for Inherited Genetic Disorders Market Share by Players in 2020 Figure 18. Global Top Gene Therapy for Inherited Genetic Disorders Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy for Inherited Genetic Disorders as of 2020 Figure 19. The Top 10 and 5 Players Market Share by Gene Therapy for Inherited Genetic Disorders Revenue in 2020 Figure 20. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Type (2016-2021) Figure 21. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Type (2022-2027) Figure 22. North America Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. North America Gene Therapy for Inherited Genetic Disorders Market Share by Type (2016-2027) Figure 24. North America Gene Therapy for Inherited Genetic Disorders Market Share by Application (2016-2027) Figure 25. North America Gene Therapy for Inherited Genetic Disorders Market Share by Country (2016-2027) Figure 26. United States Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Canada Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Gene Therapy for Inherited Genetic Disorders Market Share by Type (2016-2027) Figure 30. Europe Gene Therapy for Inherited Genetic Disorders Market Share by Application (2016-2027) Figure 31. Europe Gene Therapy for Inherited Genetic Disorders Market Share by Country (2016-2027) Figure 32. Germany Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. France Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. U.K. Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Italy Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Russia Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Nordic Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Share by Type (2016-2027) Figure 40. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Share by Application (2016-2027) Figure 41. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Share by Region (2016-2027) Figure 42. China Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Japan Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. South Korea Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. India Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Australia Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Gene Therapy for Inherited Genetic Disorders Market Share by Type (2016-2027) Figure 50. Latin America Gene Therapy for Inherited Genetic Disorders Market Share by Application (2016-2027) Figure 51. Latin America Gene Therapy for Inherited Genetic Disorders Market Share by Country (2016-2027) Figure 52. Mexico Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Brazil Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Share by Type (2016-2027) Figure 56. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Share by Application (2016-2027) Figure 57. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Share by Country (2016-2027) Figure 58. Turkey Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Saudi Arabia Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. UAE Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. BioMarin Pharmaceutical Inc. Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2016-2021) Figure 62. bluebird bio Inc. Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2016-2021) Figure 63. Novartis AG Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2016-2021) Figure 64. Orchard Therapeutics Plc Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2016-2021) Figure 65. Spark Therapeutics Inc. Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

BioMarin Pharmaceutical Inc. bluebird bio Inc. Novartis AG Orchard Therapeutics Plc Spark Therapeutics Inc.